Sanofi, Teva Collaborate on Inflammatory Bowel Disease Drug
By Pierre Bertrand Sanofi said that it has entered into an exclusive collaboration with Teva Pharmaceuticals for the development of a novel therapy to treat...
Stay updated with breaking news from Sny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Pierre Bertrand Sanofi said that it has entered into an exclusive collaboration with Teva Pharmaceuticals for the development of a novel therapy to treat...
The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.
Collaboration on inflammatory bowel disease treatment seen as a 'hot asset'
HF Advisory Group LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 3.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,523 shares of the company’s stock after buying an additional 349 shares during the quarter. […]
DAVENPORT & Co LLC grew its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 1.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,191,542 shares of the company’s stock after buying an additional 18,656 shares during the quarter. DAVENPORT & Co LLC’s […]